Skip to content
HowShorted

Palisade Bio, Inc. short interest in 2018

In 2018, Palisade Bio, Inc.'s disclosed short interest ran from 6.93% of shares outstanding on 12 Jan 2018 to 1.82% on 31 Dec 2018, a change of -5.11 percentage points. The year's high was 6.93% on 12 Jan 2018 and its low 1.82% on 31 Dec 2018, averaging 4.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.24 days on 13 Jul 2018. Full history: Palisade Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026

Aggregate net short position time series for Palisade Bio, Inc. in 2018

2018 in figures

Start of year
6.93% (12 Jan 2018)
End of year
1.82% (31 Dec 2018)
Change
-5.11 pp
High
6.93% (12 Jan 2018)
Low
1.82% (31 Dec 2018)
Average
4.32%
Highest days to cover
11.24 (13 Jul 2018)
SEC filings marked
8

Every report in 2018

Palisade Bio, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20186.93%1.94
31 Jan 20186.63%4.61
15 Feb 20186.13%6.55
28 Feb 20185.50%4.86
15 Mar 20185.04%5.46
29 Mar 20185.16%8.64
13 Apr 20185.06%1.9610-K filed, results (8-K)
30 Apr 20184.53%5.34
15 May 20184.15%4.2810-Q filed, results (8-K)
31 May 20183.96%10.85
15 Jun 20183.64%4.59
29 Jun 20183.66%4.24
13 Jul 20183.73%11.24
31 Jul 20184.21%2.82
15 Aug 20184.46%5.0710-Q filed, results (8-K)
31 Aug 20183.73%6.31
14 Sep 20184.06%10.44
28 Sep 20183.95%10.68
15 Oct 20183.67%7.09
31 Oct 20183.85%1.31
15 Nov 20183.38%3.5910-Q filed
30 Nov 20183.21%8.07results (8-K)
14 Dec 20183.19%4.95
31 Dec 20181.82%2.29

See also: Palisade Bio, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.